ArticleAngewandte Chemie (International ed. in English)2026
Biosynthesis and Genetic Tuning of Guanine Crystals via Metabolic Engineering of Yeast.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Purine crystals, such as guanine, generate diverse optical phenomena in animals and function as important nitrogen-storage reservoirs in microalgae. Here, we demonstrate the formation of guanine crystals in Brewer's yeast. Whilst guanine crystals do not naturally contribute to the physiology of this yeast species, we show how crystallization may be artificially induced and then use genetic manipulation to control crystal properties. Specifically, we use genetic knockouts of purine salvage enzymes to modify crystal morphology, size and crystalline order. Deletion of Hpt1 and Gud1, which convert guanine to guanosine monophosphate and xanthine, respectively, transforms spherical guanine nanoparticles in wild-type cells into crystalline dumbbells and nanoflowers. While we are lacking a definitive mechanism to rationalize this transformation, we hypothesize that changes in crystal morphology are likely driven by genetically induced shifts in the local supersaturation and metabolite composition within the yeast vacuole. Leveraging yeast's genetic programmability and ubiquitous industrial usage, our findings provide a powerful biotechnological strategy for the biosynthesis of optically functional guanine crystals, as environmentally friendly alternatives to toxic pigments in a range of industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.